Where does Avive Solutions, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Avive Solutions, Inc. ranks #7,118 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Avive Solutions, Inc. hold?

Avive Solutions, Inc. holds 46 US utility patents granted between 2020 and 2025, spanning 12 technology areas.

What is Avive Solutions, Inc.'s Innovation Score?

Avive Solutions, Inc. has an Innovation Score of 44.7 out of 100 (top 25% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Avive Solutions, Inc. focus on?

Avive Solutions, Inc.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 40 patents, ranking #96 of 1,943 assignees active in that subclass. Grants appear in 12 CPC subclasses total.

Is Avive Solutions, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Avive Solutions, Inc..

What does claim depth mean for Avive Solutions, Inc.'s patents?

Avive Solutions, Inc.'s patents average 22.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Avive Solutions, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Avive Solutions, Inc.

USPTO PatentsView assignee record - 46 granted patents across 12 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Avive ranks #7,118 of 49,997 tracked US assignees by granted-patent volume, with 46 patents across 12 technology areas.

#7,118
of 49,997 US assignees by volume: Top 25%
by Innovation Score (44.7/100): 22.4
avg claims per patent

USPTO PatentsView assignee plate

Corpus R7118 · US Corporation #7,118 · 46 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-SMALL 46 grants
UPPER-Q #7,118/49,997
PHOTO-FINISH Anton Paar
CPC-FOCUS A61N · 12 areas
INNOV-PAR 44.7/100
CLAIMS-DENSE 22.4 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2020–2025 · 6y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Anton Paar GmbH (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Avive’s 44.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.3 pts (30%) Velocity 5.7 pts (13%) Breadth 12.2 pts (27%) Claim depth 13.5 pts (30%)

Qualcomm Incorporated · highest

85
Adrian Steel · near

45
Avive Solutions · this assignee

45
Osaka Prefecture… · near

45
Puzzle Medical Devices · near

45
Shengyi Technology · near

45
3D Lighting… · lowest

7

What this shows Avive's Innovation Score is 44.7/100 (top 25% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Avive?

Each dot is one of Avive’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Avive’s own 22.4 claims/patent is ABOVE the 14.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Avive vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Avive's grants concentrate

Avive Solutions, Inc. is a focused PatentsView assignee: 12 CPC subclasses with 87% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2021 (12 grants) versus a trough of 5 in 2023. By volume, Avive sits between Anton Paar GmbH and BÜHLER Motor GMBH.

Avive's three-year grant acceleration

From 2019–2021 to 2022–2024, Avive Solutions, Inc. moved from 21 to 18 grants (0.86x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Anton Paar

46
Araxes Pharma

46
Artisan Vehicle S…

46
Auspex Pharmaceut…

46
Binj Laboratories

46
Bradshaw Internat…

46
Breeo

46
BÜHLER Motor

46
Avive Solutions ◀

46

What this shows Avive holds 46 patents at rank #7,118, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Avive

By rank, the assignees closest to #7,118 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Avive's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Avive, neither rank-band nor same-CPC leaders (those blocks stay above). In A61N (Electrotherapy), Avive ranks #96 of 1,943 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (45 here).

Osaka Prefecture University Public Corporation 45 Shengyi Technology Co., Ltd. 45 Puzzle Medical Devices Inc. 45 Adrian Steel Company 45

Avive's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

45 Top 25% higher than 75% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Avive Solutions, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	9	19.6%
2021	12	26.1%
2022	6	13.0%
2023	5	10.9%
2024	7	15.2%
2025partial year	7	15.2%

Which technologies does Avive Solutions, Inc. patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 40

H04W - Wireless Communication Networks 28

G08B - Signalling OR Calling SYSTEMS; Order TELEGRAPHS; Alarm Systems 18

G06F - Electric Digital Data Processing 13

H04L - Transmission OF Digital Information, e.g. Telegraphic Communication 12

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 11

H02J - Circuit Arrangements OR Systems FOR Supplying OR Distributing Electric POWER; Systems FOR Storing Electric Energy 8

A61B - DIAGNOSIS; SURGERY; Identification 7

H01R - Electrically-conductive CONNECTIONS; Structural Associations OF A Plurality OF Mutually-insulated Electrical Connecting ELEMENTS; Coupling DEVICES; Current Collectors 6

G06N - Computing Arrangements Based ON Specific Computational Models 2

G02F - Optical Devices OR Arrangements FOR THE Control OF Light BY Modification OF THE Optical Properties OF THE Media OF THE Elements Involved THEREIN; Non-linear OPTICS; Frequency-changing OF LIGHT; Optical Logic ELEMENTS; Optical ANALOGUE/DIGITAL Converters 1

H04M - Telephonic Communication 1

Top 12 of 12 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Avive Solutions, Inc.'s patent record in context - here's where to go next.

Avive Solutions, Inc.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 87% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #7,118 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Avive Solutions, Inc. against Anton Paar GmbH, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 44.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.